BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 12, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 15, 2020
View Archived Issues
The next pandemic: fire breaks and host-directed therapies
Read More
Rejuvenating inflammation's end
Read More
Dose-expansion phase I data for trastuzumab deruxtecan in multiple advanced cancers
Read More
First-in-human data for telisotuzumab in advanced solid tumors
Read More
AstraZeneca initiates CALAVI study of Calquence against COVID-19
Read More
FDA approves IND application for GT-103
Read More
Moderna reports interim phase I data for mRNA-1893 vaccine
Read More
Positive topline phase I data reported for ADX-629
Read More
Sanofi and GSK collaborate to develop an adjuvanted vaccine for COVID-19
Read More
7 Hills Pharma cleared to conduct phase I study of 7HP349 in U.S.
Read More
Tocilizumab shows promise in single-center study in patients with COVID-19
Read More
Galectin-3 predicts prognosis in sudden cardiac arrest in out-of-hospital patients
Read More
Incyte discovers inhibitors of ALK2 and/or FGFR
Read More
New N-acetyl-beta-D-glucosaminidase inhibitors identified at Lilly
Read More
Fochon Pharmaceuticals, Shanghai Fochon Pharmaceutical patent RET inhibitors
Read More
New histamine H3 receptor antagonists identified at XW Laboratories
Read More
Suzhou Raymon Pharmaceuticals presents PI3K inhibitors
Read More
SP-8008 prevents thrombus formation without inducing bleeding by blocking vWF-GP Ib interaction
Read More
SST3-peptide agonists reduce nonfunctioning pituitary tumor cell viability and inhibit tumor growth
Read More
Upregulated serum markers identified in patients with LGE-negative DMD
Read More
Topoisomerase 2-beta knockdown yields model of diastolic dysfunction
Read More
Daiichi Sankyo studies DS-6157a for advanced GIST in first-in-human trial
Read More
Enrollment opens in phase I study of ALPN-202 for advanced malignancies
Read More
Oragenics reports early topline data from phase II study of AG-013 for oral mucositis
Read More
